A

Ascension | St. Clair Nephrology Research

Research site
(Unclaimed)
Location
18001 East 10 Mile Road, Suite 3, Roseville, Michigan, United States of America

Site insights

Top conditions

Top treatments

VX-147
Lesinurad
BI 764198
RGLS8429
RGLS4326
Cyclosporine
CXA-10
Tacrolimus

Parent organization

This site is a part of Ascension

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 8 total trials

A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease

The purpose of this study is to assess the safety and efficacy (including durability) of up to 2 REACT injections given 3 months (+30 days) apart and...

Active, not recruiting
Chronic Kidney Diseases
Type 2 Diabetes Mellitus
Biological: Renal Autologous Cell Therapy (REACT)

Primary ObjectivesTo assess the safety and tolerability of RGLS8429To assess the impact of RGLS8429 on ADPKD biomarkersSecondary ObjectivesTo assess...

Enrolling
ADPKD
Polycystic Kidney, Autosomal Dominant
Drug: RGLS8429
Drug: Placebo

This study is open to adults with a type of kidney disease called focal segmental glomerulosclerosis (FSGS). The purpose of this study is to find out...

Enrolling
Kidney Disease, Chronic
Drug: Placebo
Drug: BI 764198

The purpose of this study is to evaluate the efficacy, safety, tolerability, and pharmacokinetics (PK) of VX-147 in adult and pediatric participants...

Enrolling
Proteinuric Kidney Disease
Drug: VX-147
Drug: Placebo

Trial sponsors

R
Boehringer Ingelheim logo
Bristol-Myers Squibb (BMS) logo
C
Ironwood Pharmaceuticals logo
P
Vertex Pharmaceuticals logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems